Recent advances in cancer biology have led to the discovery and development of chemical compounds and drugs that target specific cellular receptors, mediators, or effectors that are central to ...

Liposomal gemcitabine in combination with pembrolizumab shows promise in the treatment of advanced solid tumors, according to a study presented at the recent American Society of Clinical Oncology ...

– Both single-agent XL092 and XL092 in combination with atezolizumab demonstrated encouraging efficacy and safety in a heavily pretreated patient population – – XL092 demonstrated preliminary clinical ...